Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jens Overgaard

Showing results (81-90 of 389) with videos related to

Pageof 39
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Reply to E. Avisar, H. Kuerer, L. Livi et al, and E. Hindié et alLise B J Thorsen, Birgitte V Offersen, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|August 22, 2019
Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumesMorten Busk, Michael R Horsman, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|April 29, 2006
Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanomaPeter Isager, Niels Ehlers, Steen F Urbak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2006
Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental modelsSlavka Lukacova, Jens Overgaard, Jan Alsner, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 19, 2012
Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assaysEmilia Wiechec, Jens Overgaard, Eigil Kjeldsen, et al.
Clinical Epidemiology|November 16, 2016
The Danish Head and Neck Cancer databaseJens Overgaard, Aleksandar Jovanovic, Christian Godballe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2005
The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment timesJesper Grau Eriksen, Jan Alsner, Torben Steiniche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2008
Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic reviewBirgitte V Offersen, Marie Overgaard, Niels Kroman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2007
In normal human fibroblasts variation in DSB repair capacity cannot be ascribed to radiation-induced changes in the localisation, expression or activity of major NHEJ proteinsUlla Kasten-Pisula, Svetlana Vronskaja, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2019
BIGART 2019 - adapting to the futureJens Overgaard, Ludvig Paul Muren, Morten Høyer, et al.
Pageof 39

Showing results (81-90 of 389) with videos related to

Sort By:
Pageof 39
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2016
Reply to E. Avisar, H. Kuerer, L. Livi et al, and E. Hindié et alLise B J Thorsen, Birgitte V Offersen, Jens Overgaard
Acta Oncologica (Stockholm, Sweden)|August 22, 2019
Dual-tracer PET of viable tumor volume and hypoxia for identification of necrosis-containing radio-resistant Sub-volumesMorten Busk, Michael R Horsman, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|April 29, 2006
Visual outcome, local tumour control, and eye preservation after 106Ru/Rh brachytherapy for choroidal melanomaPeter Isager, Niels Ehlers, Steen F Urbak, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2006
Strain and tumour specific variations in the effect of hypoxia on osteopontin levels in experimental modelsSlavka Lukacova, Jens Overgaard, Jan Alsner, et al.
Cellular Oncology (Dordrecht, Netherlands)|December 19, 2012
Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assaysEmilia Wiechec, Jens Overgaard, Eigil Kjeldsen, et al.
Clinical Epidemiology|November 16, 2016
The Danish Head and Neck Cancer databaseJens Overgaard, Aleksandar Jovanovic, Christian Godballe, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 19, 2005
The possible role of TP53 mutation status in the treatment of squamous cell carcinomas of the head and neck (HNSCC) with radiotherapy with different overall treatment timesJesper Grau Eriksen, Jan Alsner, Torben Steiniche, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 12, 2008
Accelerated partial breast irradiation as part of breast conserving therapy of early breast carcinoma: a systematic reviewBirgitte V Offersen, Marie Overgaard, Niels Kroman, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 26, 2007
In normal human fibroblasts variation in DSB repair capacity cannot be ascribed to radiation-induced changes in the localisation, expression or activity of major NHEJ proteinsUlla Kasten-Pisula, Svetlana Vronskaja, Jens Overgaard, et al.
Acta Oncologica (Stockholm, Sweden)|October 24, 2019
BIGART 2019 - adapting to the futureJens Overgaard, Ludvig Paul Muren, Morten Høyer, et al.
Pageof 39